Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion

The optimal treatment of chronic middle cerebral artery (MCA) occlusion is unclear. Angioplasty and stenting may be an alternative treatment for patients with recurrent ischemic symptoms despite medical therapy. Two patients with chronic right MCA occlusion successfully treated with stenting are rep...

Full description

Bibliographic Details
Main Authors: Ma, Ning, Mo, Da-Peng, Gao, Feng, Miao, Zhong-Rong
Format: Online
Language:English
Published: BMJ Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623035/
id pubmed-3623035
recordtype oai_dc
spelling pubmed-36230352013-04-11 Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion Ma, Ning Mo, Da-Peng Gao, Feng Miao, Zhong-Rong Electronic Pages The optimal treatment of chronic middle cerebral artery (MCA) occlusion is unclear. Angioplasty and stenting may be an alternative treatment for patients with recurrent ischemic symptoms despite medical therapy. Two patients with chronic right MCA occlusion successfully treated with stenting are reported, together with their long term follow-up to illustrate the feasibility of endovascular recanalization. One patient remained asymptomatic at the 29-month follow-up. Another patient developed symptomatic in-stent restenosis at 12 months which resolved after repeat angioplasty. Further larger scale pilot studies are needed to determine the efficacy and long term outcome of this treatment. BMJ Group 2013-05 2012-04-11 /pmc/articles/PMC3623035/ /pubmed/22496065 http://dx.doi.org/10.1136/neurintsurg-2012-010304 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ma, Ning
Mo, Da-Peng
Gao, Feng
Miao, Zhong-Rong
spellingShingle Ma, Ning
Mo, Da-Peng
Gao, Feng
Miao, Zhong-Rong
Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
author_facet Ma, Ning
Mo, Da-Peng
Gao, Feng
Miao, Zhong-Rong
author_sort Ma, Ning
title Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
title_short Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
title_full Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
title_fullStr Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
title_full_unstemmed Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
title_sort endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
description The optimal treatment of chronic middle cerebral artery (MCA) occlusion is unclear. Angioplasty and stenting may be an alternative treatment for patients with recurrent ischemic symptoms despite medical therapy. Two patients with chronic right MCA occlusion successfully treated with stenting are reported, together with their long term follow-up to illustrate the feasibility of endovascular recanalization. One patient remained asymptomatic at the 29-month follow-up. Another patient developed symptomatic in-stent restenosis at 12 months which resolved after repeat angioplasty. Further larger scale pilot studies are needed to determine the efficacy and long term outcome of this treatment.
publisher BMJ Group
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623035/
_version_ 1611969410336030720